إعلان
إعلان

BSX

BSX logo

Boston Scientific Corp.

94.57
USD
برعاية
-0.78
-0.82%
٠٢ يناير, ١٢:٢٨ UTC -5
مفتوح

تقارير أرباح BSX

النسبة الإيجابية المفاجئة

BSX تفوق 31 من 39 آخر التقديرات.

79%

التقرير التالي

بيانات التقرير القادم
٠٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$5.33B
/
$0.78
التغير الضمني من Q3 25 (Revenue/ EPS)
+5.25%
/
+4.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+16.88%
/
+11.43%

Boston Scientific Corp. earnings per share and revenue

On ٢٢ أكتوبر ٢٠٢٥, BSX reported earnings of 0.75 USD per share (EPS) for Q3 25, beating the estimate of 0.72 USD, resulting in a 4.07% surprise. Revenue reached 5.07 مليار, compared to an expected 5.02 مليار, with a 0.96% difference. The market reacted with a +3.95% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 29 analysts forecast an EPS of 0.78 USD, with revenue projected to reach 5.33 مليار USD, implying an increase of 4.00% EPS, and increase of 5.25% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Boston Scientific Corp. reported EPS of $0.75, beating estimates by 4.07%, and revenue of $5.07B, 0.96% above expectations.
The stock price moved up 3.95%, changed from $99.90 before the earnings release to $103.85 the day after.
The next earning report is scheduled for ٠٣ فبراير ٢٠٢٦.
Based on 29 analysts, Boston Scientific Corp. is expected to report EPS of $0.78 and revenue of $5.33B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان